As of April 29, 2025, Pulmatrix (PULM) has a market cap of $23.009 million USD. According to our data, Pulmatrix is ranked No.8514 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $23.01 M |
-9.74%
|
Dec 31, 2024 | $25.49 M |
275.27%
|
Dec 29, 2023 | $6.79 M |
-52.06%
|
Dec 30, 2022 | $14.17 M |
-55.71%
|
Dec 31, 2021 | $31.99 M |
-63.19%
|
Dec 31, 2020 | $86.92 M |
38.37%
|
Dec 31, 2019 | $62.82 M |
-64.17%
|
Dec 31, 2018 | $0.18 B |
-82.98%
|
Dec 29, 2017 | $1.03 B |
138.98%
|
Dec 30, 2016 | $0.43 B |
-85.95%
|
Dec 31, 2015 | $3.07 B |
-52.00%
|
Dec 31, 2014 | $6.39 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Innoviva
INVA
|
$1.16 B |
-0.000 M
|
![]() USA
|
![]() Amphastar Pharmaceuticals
AMPH
|
$1.16 B |
0.000 M
|
![]() USA
|
![]() MannKind Corp
MNKD
|
$1.49 B |
0.000 M
|
![]() USA
|
![]() Insmed
INSM
|
$12.98 B |
0.000 M
|
![]() USA
|
![]() Theravance Biopharma
TBPH
|
$0.48 B |
0.000 M
|
|
![]() Verona Pharma
VRNA
|
$9.75 B |
3.521 B
|
![]() UK
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Teva Pharmaceutical Industries
TEVA
|
$18.23 B |
0.362 B
|
![]() Israel
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
Market Cap | = | PULM Stock Price | * | PULM Shares Outstanding |
= | $6.30 | * | 3.65 M | |
= | $23.01 M |